BioCentury | Aug 14, 2018
Company News

Management tracks: Cheng departing Gilead as CMO

...CBO David Lawrence and CMO Burkhard Blank will assume responsibility for manufacturing and technical operations. A1M Pharma...
BioCentury | Jun 23, 2016
Tools & Techniques

Home is in the placenta

...placenta-specific therapeutics," and the team has already begun collaborating with Stefan Hansson, a co-founder of A1M Pharma...
...of the Perinatal Laboratory at Lund University , to deliver recombinant A1M to the placenta. A1M Pharma...
...for placenta-specific peptides will identify some that could provide new IP. Companies and Institutions Mentioned A1M Pharma...
BioCentury | Apr 21, 2016
Product R&D

A1M for preeclampsia

...development pathway have kept most drug developers away from the serious pregnancy complication preeclampsia, but A1M Pharma...
...A1M Pharma is actively seeking development partners. (See Table: Biocentury Product Profile) Companies and Institutions Mentioned A1M Pharma...
...Company; lead investigator A1M Pharma AB (AktieTorget:A1M), Lund University; Bo Åkerström, Stefan Hansson Figures Placental protection A1M Pharma...
BioCentury | Mar 31, 2014
Company News

A1M Pharma, NeuroVive deal

...brain injury (TBI). NeuroSTAT has Orphan Drug designation in the U.S. and EU for TBI. A1M Pharma...
Items per page:
1 - 4 of 4
BioCentury | Aug 14, 2018
Company News

Management tracks: Cheng departing Gilead as CMO

...CBO David Lawrence and CMO Burkhard Blank will assume responsibility for manufacturing and technical operations. A1M Pharma...
BioCentury | Jun 23, 2016
Tools & Techniques

Home is in the placenta

...placenta-specific therapeutics," and the team has already begun collaborating with Stefan Hansson, a co-founder of A1M Pharma...
...of the Perinatal Laboratory at Lund University , to deliver recombinant A1M to the placenta. A1M Pharma...
...for placenta-specific peptides will identify some that could provide new IP. Companies and Institutions Mentioned A1M Pharma...
BioCentury | Apr 21, 2016
Product R&D

A1M for preeclampsia

...development pathway have kept most drug developers away from the serious pregnancy complication preeclampsia, but A1M Pharma...
...A1M Pharma is actively seeking development partners. (See Table: Biocentury Product Profile) Companies and Institutions Mentioned A1M Pharma...
...Company; lead investigator A1M Pharma AB (AktieTorget:A1M), Lund University; Bo Åkerström, Stefan Hansson Figures Placental protection A1M Pharma...
BioCentury | Mar 31, 2014
Company News

A1M Pharma, NeuroVive deal

...brain injury (TBI). NeuroSTAT has Orphan Drug designation in the U.S. and EU for TBI. A1M Pharma...
Items per page:
1 - 4 of 4